美股异动 | 和黄医药(HCM.US)涨近4% SAFFRON III期研究取得积极结果

智通财经
Aug 17
【美股异动 | 和黄医药(HCM.US)涨近4% SAFFRON III期研究取得积极结果】智通财经APP获悉,周一,和黄医药(HCM.US)涨近4%,报12.67美元。消息面上,8月17日,和黄医药发布公告,宣布沃瑞沙(赛沃替尼)与泰瑞沙(奥希替尼)联合疗法的SAFFRON III期研究取得积极顶线结果。该研究针对既往接受过泰瑞沙治疗后疾病进展、且肿瘤伴有高水平MET过表达或扩增的EGFR突变非小细胞肺癌患者。研究结果显示,联合疗法对比铂类双药化疗,在无进展生存期(PFS)和总生存期(OS)上均具有统计学和临床意义的改善。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10